Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Aviscumine, a recombinant ribosomal inhibitor, increases the antitumor activity of natural killer cells.

Gamerith G, Amann A, Schenk B, Auer T, Lentzen H, Mügge DO, Cima KM, Löffler-Ragg J, Hilbe W, Zwierzina H.

Oncol Lett. 2017 Nov;14(5):5563-5568. doi: 10.3892/ol.2017.6861. Epub 2017 Aug 31.

2.

Subarachnoid haemorrhage mimicking a STEMI.

Cima K, Grams A, Metzler B.

Eur Heart J Acute Cardiovasc Care. 2017 Dec;6(8):736-737. doi: 10.1177/2048872616655942. Epub 2016 Jun 17.

PMID:
27316565
3.

The German adaptation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR).

Cima K, Twiss J, Speich R, McKenna SP, Grünig E, Kähler CM, Ehlken N, Treder U, Crawford SR, Huber LC, Ulrich S.

Health Qual Life Outcomes. 2012 Sep 13;10:110. doi: 10.1186/1477-7525-10-110.

4.

Successful treatment of portopulmonary hypertension with the selective endothelin receptor antagonist Sitaxentan.

Kähler CM, Graziadei I, Vogelsinger H, Desole S, Cima K, Vogel W.

Wien Klin Wochenschr. 2011 Apr;123(7-8):248-52. doi: 10.1007/s00508-011-1540-4. Epub 2011 Mar 31.

PMID:
21451953
5.

Sensory neuropeptides are potent chemoattractants for human basophils in vitro.

Cima K, Vogelsinger H, Kähler CM.

Regul Pept. 2010 Feb 25;160(1-3):42-8. doi: 10.1016/j.regpep.2009.12.013. Epub 2009 Dec 24.

PMID:
20035805

Supplemental Content

Support Center